Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1655
-0.0028(-0.24%)
GBP/USD
1.2550
+0.0017(+0.14%)
Bitcoin GBP
49,722.70
+2,428.18(+5.13%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

110.01

+0.72

(+0.66%)

At close: 04:00PM EDT

105.45

-4.56

(-4.15%)

After hours:

04:18PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	6.89B
Enterprise value	10.86B
Trailing P/E	22.63
Forward P/E	5.87
PEG ratio (5-yr expected)	0.83
Price/sales (ttm)	1.97
Price/book (mrq)	1.86
Enterprise value/revenue	2.82
Enterprise value/EBITDA	9.30

Trading information

Stock price history

Beta (5Y monthly)	0.61
52-week change ³	-21.60%
S&P500 52-week change ³	22.43%
52-week high ³	146.70
52-week low ³	103.01
50-day moving average ³	117.04
200-day moving average ³	125.17

Share statistics

Avg vol (3-month) ³	622.36k
Avg vol (10-day) ³	621.16k
Shares outstanding ⁵	63.04M
Implied shares outstanding ⁶	62.35M
Float ⁸	60.74M
% held by insiders ¹	2.79%
% held by institutions ¹	96.76%
Shares short (15 Apr 2024) ⁴	3.7M
Short ratio (15 Apr 2024) ⁴	5.44
Short % of float (15 Apr 2024) ⁴	7.73%
Short % of shares outstanding (15 Apr 2024) ⁴	5.87%
Shares short (prior month 15 Mar 2024) ⁴	2.77M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	8.61%
Operating margin (ttm)	11.66%

Management effectiveness

Return on assets (ttm)	4.07%
Return on equity (ttm)	9.41%

Income statement

Revenue (ttm)	3.84B
Revenue per share (ttm)	60.96
Quarterly revenue growth (yoy)	1.00%
Gross profit (ttm)	N/A
EBITDA	1.37B
Net income avi to common (ttm)	330.79M
Diluted EPS (ttm)	4.83
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.82B
Total cash per share (mrq)	29.08
Total debt (mrq)	5.77B
Total debt/equity (mrq)	156.00%
Current ratio (mrq)	2.27
Book value per share (mrq)	59.11

Cash flow statement

Operating cash flow (ttm)	1.04B
Levered free cash flow (ttm)	1.06B